COMPARISON OF EXTRACELLULAR SECRETION OF RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR USING TORA AND PELB SIGNAL PEPTIDES IN ESCHERICHIA COLI BL21 (DE3)
Objective: The objective of this study was to evaluate two signal peptides (TorA and PelB), representing the most common secretion pathways in Escherichia coli, for their ability to secrete recombinant human epidermal growth factor (rhEGF) protein in the extracellular expression.
Methods: E. coli BL21 (DE3) as the host cell to be transformed using recombinant plasmid pD881-TorA the consensus already containing hEGF gene and the signal peptide TorA or PelB, then expressed by L-rhamnose induction. rhEGF purified by heat treatment and ion-exchange chromatography. The hEGF protein was characterized using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and ELISA.
Results: The result showed that PelB was secreting more hEGF protein compared to TorA with protein expression results of 48.2 μg/L and purification results of 0.360 μg/L, with a purity level of 83%.
Conclusion: The results of this study explain in extracellular expression of hEGF protein in E. coli, PelB helps hEGF protein secretion to culture media better than TorA.
2. Shimizu N, Fukuzono S, Harada Y, Fujimori K, Gotoh K, Yamazaki Y. Mass production of human epidermal growth factor using fed batch cultures of recombinant Escherichia coli. Biotechnol Bioeng 1991;38:37-42.
3. Natale P, Thomas B, Arnold JM. Sec and tat-mediated protein secretion across the bacterial cytoplasmic membrane-distinct translocases and mechanism. Biochim Biophy Acta 2007;1778:1735-56.
4. Indriyani A, Aggraeni AI, Sriwidodo. Maksum IP. Optimization extracellular secretion of recombinant human epidermal growth factor (hEGF) in Escherichia coli BL21 (DE3) pD881-OmpA-hEGF by using response surface method (RSM). J Res Pharm Sci 2019;10:1824-31.
5. Freudl R. Signal peptides for recombinant protein secretion in bacterial expression systems. Microb Cell Fact 2018;17:52.
6. Cohen S, Carpenter G, Human epidermal growth factor: Isolation and chemical and biological properties. Proc. Natl Acad Sci U S A 1975;72:1317-21.
7. Tiaka EK, Papanas N, Manolakis AC, Georgiadis GS. Epidermal growth factor in the treatment of diabetic foot ulcers: An update. Perspect Vasc Surg Endovasc Ther 2012;24:37-44.
8. Zheng X, Wu X, Fu X, Dai D, Wang F. Expression and purification of human epidermal growth factor (hEGF) fused with GB1. Biotechnol Biotechnol Equip 2016;30:813-8.
9. Su Y, Huang Y, Zhou Q, Wu Z, Wu X, Zheng Q, et al. High-Level expression and purification of human epidermal growth factor with SUMO fusion in Escherichia coli. Protein Pept Lett 2006;13:785-92.
10. Maksum IP, Utama E, Sriwidodo, Subroto T. Extracellular secretion of recombinant human epidermal growth factor by using trimethylamine N-Oxide reductase A (TorA) signal peptide in Escherichia coli BL21 (DE3). J Pharm Sci Res 2017;9:1007-16.
11. Haider SR, Reid HJ, Sharp BL. Tricine-sds-page. Methods Mol Biol 2012;869:81-91.
12. Lowry HO, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951;193:265-75.
13. Carpenter G, Cohen S. Epidermal growth factor. Annu Rev Biochem 1979;48:193-216.
14. Li YL, Tian Z, Zhao L, Zhang CL. Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: A meta analysis and meta-regression. Genet Mol Res 2014;13:8066-79.
15. Taylor JM, Mitchell WM, Cohen S. Epidermal growth factor. Physical and chemical properties. J Biol Chem 1972;247:5928-34.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.